Regional Blood Flow Clinical Trial
— Dunhill01Official title:
Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance in Older People
Verified date | November 2012 |
Source | University of Nottingham |
Contact | n/a |
Is FDA regulated | No |
Health authority | United Kingdom: Research Ethics Committee |
Study type | Interventional |
With age, muscles tend to waste at 0.5-1% per year, so that an 80 year old may have only 70% of the muscle possessed at 50. Muscle loss makes it harder to carry out tasks that require strength, keep the body balanced and continue activity for a prolonged period, which together may contribute to a loss of independence and an increased risk of falls. The cause of some of this muscle loss with ageing appears to be a reduction in muscle building in response to food. The known decreased limb blood flow in ageing muscle may go some way to explain this as there may be less nutrient delivery to the muscles. The investigators want to test if the known decrease in limb blood flow with age is matched with a decrease in the proportion of blood being delivered directly to the muscles, rather than fat and connective tissue. If so the investigators expect to see an improvement in the ability of muscles to maintain themselves via better capture of amino acids into protein. The investigators also want to test if 20 weeks resistance exercise training or drinking a cocktail of mixture of high flavanol cocoa (which can increase blood flow) and vitamin C can improve limb blood flow to older muscles and help reduce muscle wasting.
Status | Completed |
Enrollment | 50 |
Est. completion date | August 2012 |
Est. primary completion date | August 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: Healthy volunteers aged 18-28 or 65-75 Exclusion Criteria: - Overt muscle wasting i.e. muscle mass is more than 1 standard deviation below normal muscle or FFM for age - A BMI < 24 or > 28 kg•m2. - Active cardiovascular disease: uncontrolled hypertension (BP > 160/100), angina, heart failure (class III/IV), arrhythmia, right to left cardiac shunt or recent cardiac event - Individuals taking beta-adrenergic blocking agents. - Cerebrovascular disease: previous stroke, aneurysm (large vessel or intracranial). - Respiratory disease including pulmonary hypertension, COPD, asthma or an FEV1 less than 1.5 l. - Metabolic disease: hyper and hypo parathyroidism, untreated hyper and hypothyroidism, Cushing's disease, types 1 or 2 diabetes. - Active inflammatory bowel disease, or renal disease, - Malignancy - Recent steroid treatment (within 6 mo), or hormone replacement therapy. - Clotting dysfunction - Musculoskeletal or neurological disorders. - Family history of early (<55y) death from cardiovascular disease - Known sensitivity to Definity or methacholine |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
United Kingdom | Clinical Physiology Laboratory, Graduate Entry Medical School, University of Nottingham, Royal Derby Hospital | Derby | Derbyshire |
Lead Sponsor | Collaborator |
---|---|
University of Nottingham | The Dunhill Medical Trust |
United Kingdom,
Phillips B, Williams J, Atherton P, Smith K, Hildebrandt W, Rankin D, Greenhaff P, Macdonald I, Rennie MJ. Resistance exercise training improves age-related declines in leg vascular conductance and rejuvenates acute leg blood flow responses to feeding and exercise. J Appl Physiol (1985). 2012 Feb;112(3):347-53. doi: 10.1152/japplphysiol.01031.2011. Epub 2011 Oct 13. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Molecular pathways regulating muscle microvascular blood volume | This outcome measure was not able to be analysed prior to completion of all studied and the subsequent primary and secondary outcome measures as molecular targets of interest were dependent upon these results. This analysis has began and should be complete by August 2013. | August 2012 - August 2013 | No |
Primary | Microvascular blood volume in response to feeding | The final study participant was completed and all microvascular blood volume data analysed by August 2012. This outcome measure is applicable to all arms of this study and refers to responsiveness to a 2 hour feed protocol. | September 2009 - August 2012 | No |
Secondary | Muscle protein metabolism in response to feeding | Muscle protein metabolism (synthesis and breakdown) in response to feeding in young and older individuals and in older individuals after exercise or nutraceutical intervention. This outcome measure could only be assessed after all studies were completed to ensure standardization of mass-spectrometry measurements between the groups. | January - October 2012 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00431691 -
Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, and Cytokine Levels in LPS Induced Inflammatory Model in Humans.
|
Phase 4 | |
Completed |
NCT00810927 -
Role of Nitrogen Oxide (NO) in the Control of Choroidal Blood Flow During a Decrease in Ocular Perfusion Pressure
|
Phase 2 | |
Completed |
NCT00431392 -
Mechanisms of Choroidal Blood Flow Changes During Dark/Light Transitions
|
Phase 2 | |
Completed |
NCT00540215 -
GLP-2 (Glucagonlike Peptide-2) and Blood Flow
|
N/A | |
Completed |
NCT02589054 -
Regional Changes in Upper Limb Perfusion Following Brachial Plexus Block: A Pilot Study
|
N/A | |
Completed |
NCT00707226 -
Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes
|
N/A | |
Completed |
NCT00709449 -
An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects
|
Phase 2/Phase 3 | |
Terminated |
NCT00708357 -
Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?
|
Phase 0 | |
Terminated |
NCT00709657 -
The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion
|
N/A | |
Completed |
NCT00709423 -
Effects of Moxaverine and Placebo on Ocular Blood Flow
|
Phase 2 | |
Completed |
NCT00814008 -
The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp
|
Phase 2 | |
Completed |
NCT00708929 -
Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid?
|
N/A | |
Completed |
NCT00712400 -
Effects of Latanoprost on Choroidal Blood Flow Regulation in Human Subjects
|
N/A | |
Completed |
NCT00312325 -
Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans
|
Phase 4 | |
Withdrawn |
NCT00312390 -
Amblyopia and Neurovascular Coupling in the Retina of Humans
|
N/A | |
Withdrawn |
NCT00406731 -
Role of Endothelin- and Nitric Oxide-system in the Regulation of Optic Nerve Head Blood Flow During Changes in Ocular Perfusion Pressure
|
Phase 2 | |
Completed |
NCT00275730 -
Effects of Indomethacin on Retinal and Choroidal Blood Flow in Healthy Volunteers
|
N/A | |
Completed |
NCT00312416 -
Effects of Topical Clonidine vs. Brimonidine on Choroidal Blood Flow and Intraocular Pressure During Isometric Exercise
|
Phase 4 | |
Completed |
NCT00712907 -
Effects of Vitamin C on Hyperoxia-Induced Reduction of Retinal Blood Flow
|
N/A | |
Withdrawn |
NCT02978560 -
Indocyanine Green Tissue Perfusion Monitoring
|